CL
Colgate-Palmolive Company
CL · NYSE
$88.03 -0.43% (-$0.38)
1M -4.64%
Market Cap $70.4B
P/E Ratio 34.58x
Div. Yield 2.39%
ROE -
Bulios Fair Price
$80.89
8.1% downside
Current Price
$88.03
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CL is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
46 /100
Fair P/E 34.58x
P/FCF 18.26x
EV/EBITDA 20.04x
Growth
73 /100
Growing EPS growth 7.28%
Book val. growth 48.74%
Rev. growth 4.29%
Profitability
96 /100
Strong Gross margin 60.42%
FCF margin 18.33%
Net margin 9.68%
Quality
99 /100
Excellent ROIC 29.91%
Asset turnover 1.25x
ROA 12.13%
Debt
51 /100
Moderate Debt/Equity 33.29x
Net debt/EBITDA 1.69x
Current ratio 1.03x
Stability
81 /100
Stable Beta 0.33x
Profitable years 6
Rev. volatility 3.56%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CL
Online
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Noel R. Wallace
Employees
33,600
Headquarters
New York City
Upcoming events
30 OCT
Earnings
Upcoming earnings report